U.S. markets closed

TILT Holdings Inc. (TLLTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4600-0.0221 (-4.58%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4821
Open0.4696
BidN/A x N/A
AskN/A x N/A
Day's Range0.4490 - 0.4930
52 Week Range0.3400 - 0.5340
Volume1,270,124
Avg. Volume1,153,610
Market Cap147.833M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-2.0790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification
    GlobeNewswire

    TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification

    Jupiter Research Now Authorized to Design, Manufacture and Distribute Medical Devices within the U.S. and AbroadPHOENIX, Jan. 12, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a provider of business solutions to the global cannabis industry that includes best-in-class inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is pleased to announce that its subsidiary, Jupiter Research, LLC (“Jupiter”), a leading inhalation technology company, has obtained ISO 13485:2016 certification of its Quality Management System for medical devices. ISO 13485:2016 certification is the latest development in the Company’s strategic expansion of its inhalation business beyond adult-use products, allowing Jupiter to supply the U.S. and European medical cannabis markets with medical-grade inhalation devices. The Company previously announced the expansion of its partnership with Kanabo Research Ltd. (“Kanabo”), to include registering its first medical device for sale in Europe via an audit under the Medical Devices Directive (“MDD”). The MDD is a European Union (“EU”) directive outlining standards manufacturers and importers must meet to legally market or sell their devices in the EU.According to a study by Data Bridge Market Research, the U.S. medical cannabis market is anticipated to grow over 20% annually, reaching over $80 billion in sales by 2027, while in Europe, Alliance Global Partners expects Germany to become a multi-billion-dollar market by 2025. As these markets grow, Jupiter looks to establish itself as the premier vaporization technology provider nationally and abroad.“We are exceptionally proud of the Jupiter team for successfully completing the ISO certification process, thus verifying our commitment to providing the cannabis industry with high-quality, safe and consistent products,” said Mark Scatterday, CEO of TILT Holdings. “This is an important milestone for Jupiter, expanding growth opportunities by enabling the development of inhalation devices designed specifically for the medical cannabis community and continuing to open doors for entry into the European medical marijuana market. With ISO certification, we are setting higher standards and providing customers with peace of mind, knowing our devices are manufactured using an even more controlled and supervised process.”ISO 13485:2016 is an internationally recognized standard for quality management of the design and manufacture of medical devices. The qualification verifies that Jupiter adequately fulfills regulatory requirements and specifications established by the International Organization for Standardization for medical device development and quality management systems. Jupiter can now design and manufacture its own medical device components, as well as act as contract manufacturer for third party companies.To learn more about TILT Holdings Inc. visit www.tiltholdings.com and https://www.tiltholdings.com/investors. For more information about Jupiter’s new products, visit https://www.jupiterresearch.com/. About TILT Holdings Inc. TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter, a wholly owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations Commonwealth Alternative Care, Inc. in Massachusetts and Standard Farms, LLC in Pennsylvania. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com. Forward-Looking Information This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the expected registration of Jupiter’s medical device for sale in Europe, the anticipated growth of worldwide medical cannabis markets, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law. By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking statements. For additional information regarding forward-looking statements and their related risks, please refer to the “Risk Factors and Uncertainties” section in the Management Discussion and Analysis of the Company for the quarter ended on September 30, 2020, which is available on the Company’s SEDAR profile at www.sedar.com. The CSE has neither approved nor disapproved the contents of this news release.Investor Relations Contact: Taylor Allison investors@tiltholdings.com Media Contact: Ellen Mellody Ellen@mattio.com 570-209-2947

  • OTC Markets Group Welcomes TILT Holdings Inc. to OTCQX
    PR Newswire

    OTC Markets Group Welcomes TILT Holdings Inc. to OTCQX

    OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, announced TILT Holdings Inc. (CSE: TILT; OTCQX: TLLTF), a global cannabis company with a portfolio that includes best-in-class inhalation technologies, business solutions, cultivation, manufacturing, processing, distribution, brands and retail, has qualified to trade on the OTCQX® Best Market. TILT Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market.

  • TILT Holdings Upgraded to OTCQX® Best Market
    GlobeNewswire

    TILT Holdings Upgraded to OTCQX® Best Market

    PHOENIX, Jan. 08, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (TILT or the Company) (CSE: TILT) (OTCQX: TLLTF), a global cannabis company with a portfolio that includes best-in-class inhalation technologies, business solutions, cultivation, manufacturing, processing, distribution, brands and retail, announced that it has been approved for immediate trading on the OTCQX Best Market (“OTCQX”), the top tier of the OTC Markets. Shares of the Company were previously traded on the OTCQB® Venture Market (“OTCQB”) and will continue to trade under the symbol “TLLTF.” “Our move to the OTCQX Best Market is a testament to TILT’s financial strength as well as our team’s commitment to delivering a higher standard of compliance, disclosure and corporate governance,” said Gary Santo, president of TILT Holdings. “Upgrading to the OTCQX will provide improved visibility into the trading of our stock and improved access for U.S. shareholders seeking to take part in TILT’s growth.”The OTCQX is intended for established, investor-focused U.S. and international companies. To qualify for the OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws, be current in their disclosure and have a professional third-party sponsor introduction. The companies found on the OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. For more information, visit www.tiltholdings.com.About TILT TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research, LLC, a wholly owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations Commonwealth Alternative Care, Inc. in Massachusetts and Standard Farms, LLC in Pennsylvania. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.Forward-Looking Information This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law. By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking statements. For additional information regarding forward-looking statements and their related risks, please refer to the “Risk Factors and Uncertainties” section in the Management Discussion and Analysis of the Company for the quarter ended on September 30, 2020, which is available on the Company’s SEDAR profile at www.sedar.com. The CSE has neither approved nor disapproved the contents of this news release. Investor Relations Contact:         Taylor Allison investors@tiltholdings.comMedia Contact:                 Ellen Mellody Ellen@mattio.com 570-209-2947